These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16682214)

  • 21. Estrogen-responsive finger protein as a new potential biomarker for breast cancer.
    Suzuki T; Urano T; Tsukui T; Horie-Inoue K; Moriya T; Ishida T; Muramatsu M; Ouchi Y; Sasano H; Inoue S
    Clin Cancer Res; 2005 Sep; 11(17):6148-54. PubMed ID: 16144914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 14-3-3sigma mediation of cell cycle progression is p53-independent in response to insulin-like growth factor-I receptor activation.
    Zhang Y; Karas M; Zhao H; Yakar S; LeRoith D
    J Biol Chem; 2004 Aug; 279(33):34353-60. PubMed ID: 15187095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front.
    Ide M; Nakajima T; Asao T; Kuwano H
    Cancer Lett; 2004 Apr; 207(2):241-9. PubMed ID: 15072834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
    Yang H; Zhao R; Lee MH
    Mol Cancer Ther; 2006 Feb; 5(2):253-60. PubMed ID: 16505098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers.
    Osada H; Tatematsu Y; Yatabe Y; Nakagawa T; Konishi H; Harano T; Tezel E; Takada M; Takahashi T
    Oncogene; 2002 Apr; 21(15):2418-24. PubMed ID: 11948426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interferon-inducible ubiquitin-protein isopeptide ligase (E3) EFP also functions as an ISG15 E3 ligase.
    Zou W; Zhang DE
    J Biol Chem; 2006 Feb; 281(7):3989-94. PubMed ID: 16352599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.
    Hustinx SR; Fukushima N; Zahurak ML; Riall TS; Maitra A; Brosens L; Cameron JL; Yeo CJ; Offerhaus GJ; Hruban RH; Goggins M
    Cancer Biol Ther; 2005 May; 4(5):596-601. PubMed ID: 15908786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of 14-3-3sigma expression in human thyroid carcinoma is epigenetically regulated by aberrant cytosine methylation.
    Lal G; Padmanabha L; Provenzano M; Fitzgerald M; Weydert J; Domann FE
    Cancer Lett; 2008 Aug; 267(1):165-74. PubMed ID: 18440129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 14-3-3σ regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation.
    Zheng G; Xiong Y; Yi S; Zhang W; Peng B; Zhang Q; He Z
    FEBS Lett; 2012 Jan; 586(2):163-8. PubMed ID: 22192357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p73-dependent induction of 14-3-3sigma increases the chemo-sensitivity of drug-resistant human breast cancers.
    Sang M; Li Y; Ozaki T; Ono S; Ando K; Yamamoto H; Koda T; Geng C; Nakagawara A
    Biochem Biophys Res Commun; 2006 Aug; 347(1):327-33. PubMed ID: 16814250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COP9 signalosome subunit 6 stabilizes COP1, which functions as an E3 ubiquitin ligase for 14-3-3σ.
    Choi HH; Gully C; Su CH; Velazquez-Torres G; Chou PC; Tseng C; Zhao R; Phan L; Shaiken T; Chen J; Yeung SC; Lee MH
    Oncogene; 2011 Dec; 30(48):4791-801. PubMed ID: 21625211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 14-3-3sigma negatively regulates the cell cycle, and its down-regulation is associated with poor outcome in intrahepatic cholangiocarcinoma.
    Kuroda Y; Aishima S; Taketomi A; Nishihara Y; Iguchi T; Taguchi K; Maehara Y; Tsuneyoshi M
    Hum Pathol; 2007 Jul; 38(7):1014-1022. PubMed ID: 17391729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.
    Fomenkov A; Zangen R; Huang YP; Osada M; Guo Z; Fomenkov T; Trink B; Sidransky D; Ratovitski EA
    Cell Cycle; 2004 Oct; 3(10):1285-95. PubMed ID: 15467455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 14-3-3sigma is a p53-regulated inhibitor of G2/M progression.
    Hermeking H; Lengauer C; Polyak K; He TC; Zhang L; Thiagalingam S; Kinzler KW; Vogelstein B
    Mol Cell; 1997 Dec; 1(1):3-11. PubMed ID: 9659898
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role of TGFß1 dependent 14-3-3σ phosphorylation at Ser69 and Ser74 in the regulation of gene transcription, stemness and radioresistance.
    Zakharchenko O; Cojoc M; Dubrovska A; Souchelnytskyi S
    PLoS One; 2013; 8(5):e65163. PubMed ID: 23741479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation.
    Kondo Y; Shen L; Cheng AS; Ahmed S; Boumber Y; Charo C; Yamochi T; Urano T; Furukawa K; Kwabi-Addo B; Gold DL; Sekido Y; Huang TH; Issa JP
    Nat Genet; 2008 Jun; 40(6):741-50. PubMed ID: 18488029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
    Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T
    Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 14-3-3σ expression is associated with poor pathological complete response to neoadjuvant chemotherapy in human breast cancers.
    Nakamura Y; Oshima K; Naoi Y; Nakayama T; Kim SJ; Shimazu K; Shimomura A; Maruyama N; Tamaki Y; Noguchi S
    Breast Cancer Res Treat; 2012 Jul; 134(1):229-36. PubMed ID: 22315133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [14-3-3sigma (stratifin), a potential tumor suppressor frequently inactivated by methylation in cancer of the breast].
    Jeanteur P
    Bull Cancer; 2000 Jul; 87(7-8):525. PubMed ID: 10969206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.